We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Molecular Diagnostic Solution Aids in Early Detection of Hepatitis

By LabMedica International staff writers
Posted on 12 Jun 2023
Print article
Image: Tianlong is helping hospitals in Thailand detect hepatitis early with its molecular diagnostic solution (Photo courtesy of Tianlong)
Image: Tianlong is helping hospitals in Thailand detect hepatitis early with its molecular diagnostic solution (Photo courtesy of Tianlong)

Over 350 million people worldwide are afflicted with viral hepatitis, with 9 out of 10 hepatitis sufferers unaware of their condition. To tackle this issue, Tianlong Science and Technology (Shaanxi, China), an innovative high-tech company specializing in molecular diagnostic products, has joined forces with public hospitals in northern Thailand. The partnership aims to provide detection for hepatitis C (HCV) and hepatitis B (HBV), facilitating early diagnosis and treatment. Tianlong's detection solution for HCV and HBV can aid in curbing the transmission of the diseases through early diagnosis and appropriate treatment.

Since October 2022, public hospitals in Thailand have successfully implemented Tianlong's HCV and HBV detection solution. The reagents developed by Tianlong for HCV and HBV detection, compatible with its PANA9600S nucleic acid extractor and Gentier 96 PCR system, enable rapid testing with high sensitivity, thereby gaining traction among high-end users. Tianlong has established a 7-year agreement with local Thai hospitals, which plan to progressively adopt its HCV and HBV detection solution. This move has paved the way for Tianlong to penetrate the Thai market and allowed it to strengthen its engagement with local high-end users.

Tianlong is determined to widen its footprint in Thailand, closely collaborating with local partners to deliver top-notch solutions and services for its customers. The company also plans to introduce its STIs kits in Thailand shortly, aiming to curb the spread of sexually transmitted infections (STIs). Tianlong anticipates that its molecular diagnostic solutions for hepatitis and other diseases will gain increasing acceptance in the local market, contributing to the health and well-being of the people in Thailand.

"Tianlong can give timely responses both online and offline when we need technical support. We have great confidence in Tianlong's products, and we would welcome more cooperation in the future," said a local hospital representative in Thailand.

Related Links:
Tianlong Science and Technology

New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
CVD Risk Test
GammaCoeur CVD Risk ELISA Test
New
Flow Cytometer
BF – 710

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.